Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
05 févr. 2019 17h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at...
Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019
21 déc. 2018 07h03 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at...
Rockwell Medical CEO Issues Press Release
23 mai 2018 11h26 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 23, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated specialty pharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...
Rockwell Medical Reports First Quarter 2018 Results
10 mai 2018 16h01 HE
|
Rockwell Medical, Inc.
Conference call at 4:30 p.m. EDT today, May 10 WIXOM, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated specialty pharmaceutical company targeting...
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA
08 mai 2018 08h30 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on its new manufacturing submission for its Calcitriol vitamin D injection, stating that...
Rockwell Medical Schedules First Quarter 2018 Earnings Call
02 mai 2018 11h10 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
Rockwell Medical Announces Triferic® Presentations at the 2018 International Congress on Peritoneal Dialysis
02 mai 2018 08h30 HE
|
Rockwell Medical, Inc.
Conference to be held May 5-8, in Vancouver, Canada WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), announced today that two Triferic® abstracts have been...
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
05 avr. 2018 08h30 HE
|
Rockwell Medical, Inc.
Three Poster Presentations with Data for Triferic Clinical Pharmacology and Peritoneal Dialysis Conference being held April 11-14 in Austin, TX WIXOM, Mich., April 05, 2018 (GLOBE NEWSWIRE) --...
Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology
20 mars 2018 08h30 HE
|
Rockwell Medical, Inc.
Oral and Poster Presentations for Triferic Clinical Pharmacology and Peritoneal Dialysis Conference being held March 27-31, 2018, in Beijing China WIXOM, Mich., March 20, 2018 (GLOBE NEWSWIRE)...
Rockwell Medical Reports Fourth Quarter and Year End 2017 Results
15 mars 2018 16h01 HE
|
Rockwell Medical, Inc.
Conference call at 4:30 p.m. EDT today WIXOM, Mich., March 15, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal...